Cargando…
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
INTRODUCTION: Migraine shows a significantly higher prevalence in women, especially during reproductive age when menstrual-related hormonal fluctuations represent the most common migraine trigger. Indeed, over 50% of patients report a higher occurrence of migraine attacks during the perimenstrual wi...
Autores principales: | Silvestro, Marcello, Orologio, Ilaria, Bonavita, Simona, Scotto di Clemente, Fabrizio, Fasano, Carla, Tessitore, Alessandro, Tedeschi, Gioacchino, Russo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586402/ https://www.ncbi.nlm.nih.gov/pubmed/34106431 http://dx.doi.org/10.1007/s40122-021-00273-w |
Ejemplares similares
-
Refractory migraine profile in CGRP‐monoclonal antibodies scenario
por: Silvestro, Marcello, et al.
Publicado: (2021) -
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
por: Russo, Antonio, et al.
Publicado: (2020) -
Migraine Treatment: Towards New Pharmacological Targets
por: Silvestro, Marcello, et al.
Publicado: (2023) -
Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
por: Silvestro, Marcello, et al.
Publicado: (2021) -
Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine
por: Silvestro, Marcello, et al.
Publicado: (2021)